Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life.
Christ SM, Schettle M, Willmann J, Ahmadsei M, Seiler A, Blum D, Guckenberger M, Andratschke N, Hertler C. Christ SM, et al. Among authors: ahmadsei m. Clin Transl Radiat Oncol. 2022 Apr 12;34:107-111. doi: 10.1016/j.ctro.2022.04.005. eCollection 2022 May. Clin Transl Radiat Oncol. 2022. PMID: 35496816 Free PMC article.
Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study.
Willmann J, Vlaskou Badra E, Adilovic S, Ahmadsei M, Christ SM, van Timmeren JE, Kroeze SGC, Mayinger M, Guckenberger M, Andratschke N. Willmann J, et al. Among authors: ahmadsei m. Radiother Oncol. 2022 Mar;168:256-264. doi: 10.1016/j.radonc.2022.01.019. Epub 2022 Jan 29. Radiother Oncol. 2022. PMID: 35101466 Free article.
Distant Metastasis Velocity as a Novel Prognostic Score for Overall Survival After Disease Progression Following Stereotactic Body Radiation Therapy for Oligometastatic Disease.
Willmann J, Vlaskou Badra E, Adilovic S, Christ SM, Ahmadsei M, Mayinger M, Tanadini-Lang S, Guckenberger M, Andratschke N. Willmann J, et al. Among authors: ahmadsei m. Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):871-882. doi: 10.1016/j.ijrobp.2022.06.064. Epub 2022 Jun 17. Int J Radiat Oncol Biol Phys. 2022. PMID: 35718253
Imaging-Based Prevalence of Oligometastatic Disease: A Single-Center Cross-Sectional Study.
Christ SM, Pohl K, Muehlematter UJ, Heesen P, Kühnis A, Willmann J, Ahmadsei M, Badra EV, Kroeze SGC, Mayinger M, Andratschke N, Huellner M, Guckenberger M. Christ SM, et al. Among authors: ahmadsei m. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):596-602. doi: 10.1016/j.ijrobp.2022.06.100. Epub 2022 Jul 28. Int J Radiat Oncol Biol Phys. 2022. PMID: 35908582
Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards.
Christ SM, Heesen P, Muehlematter UJ, Pohl K, William Thiel G, Willmann J, Ahmadsei M, Kroese TE, Mayinger M, Balermpas P, Wicki A, Andratschke N, Huellner M, Guckenberger M. Christ SM, et al. Among authors: ahmadsei m. Clin Transl Radiat Oncol. 2022 Nov 15;38:123-129. doi: 10.1016/j.ctro.2022.11.008. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36420098 Free PMC article.
29 results